AnalystsJay OlsonJay Olson's Stock Forecasts
AnalystsJay Olson
Analyst Ranking
Top 3%
#121 out of 4176 analysts
Average Return
+17.58%
Win Rate
47%48 out of 102
Risk vs Reward
Poor
Good
Jay Olson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +476.89% | $2.64 | $15.23 | 2022-05-12 - 2023-03-31 | Buy |
89bio IncETNB | +372.98% | $3.22 | $15.23 | 2022-06-29 - 2023-03-31 | Buy |
Prothena Corp Public Ltd CoPRTA | +357.12% | $12.08 | $55.22 | 2020-07-08 - 2021-07-08 | Buy |
Madrigal Pharmaceuticals IncMDGL | +275.95% | $64.44 | $242.26 | 2022-05-09 - 2023-03-31 | Buy |
Biovie IncBIVI | +227.40% | $2.81 | $9.20 | 2022-03-14 - 2023-03-14 | Buy |
Jay Olson Analyst Color
Get additional color on Jay Olson's coverage of popular stocks
Jay Olson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | 1 | Buy | $30.00 | +80.18% | Maintains | 4 days ago |
Cognition Therapeutics IncCGTX | 2 | Buy | $9.00 | +354.55% | Reiterates | 8 days ago |
Seagen IncSGEN | 8 | Buy | $229.00 | +13.10% | Maintains | 18 days ago |
Voyager Therapeutics IncVYGR | 3 | Buy | $14.00 | +81.58% | Initiates Coverage On | 23 days ago |
Cymabay Therapeutics IncCBAY | 2 | Buy | $12.00 | +37.61% | Maintains | 25 days ago |
Nektar TherapeuticsNKTR | 2 | Hold | $3.00 | +326.74% | Maintains | a month ago |
Denali Therapeutics IncDNLI | 2 | Buy | $70.00 | +203.82% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 5 | Hold | $20.00 | +6.27% | Maintains | a month ago |
Revolution Medicines IncRVMD | 2 | Buy | $35.00 | +61.59% | Maintains | a month ago |
Madrigal Pharmaceuticals IncMDGL | 3 | Buy | $300.00 | +23.83% | Maintains | a month ago |
Intellia Therapeutics IncNTLA | 5 | Buy | $93.00 | +149.53% | Maintains | a month ago |
Crispr Therapeutics AgCRSP | 4 | Buy | $102.06 | +125.65% | Maintains | a month ago |
89bio IncETNB | 3 | Buy | $18.00 | +18.19% | Maintains | a month ago |
Biogen IncBIIB | 11 | Buy | $310.00 | +11.50% | Maintains | a month ago |
Biovie IncBIVI | 2 | Buy | $12.00 | +48.51% | Reiterates | 2 months ago |
Amgen IncAMGN | 9 | Buy | $294.00 | +21.61% | Maintains | 2 months ago |
Mirati Therapeutics IncMRTX | 5 | Hold | $60.00 | +61.38% | Maintains | 4 months ago |
Cincor Pharma IncCINC | 3 | Hold | N/A | N/A | Downgrades | 4 months ago |
Editas Medicine IncEDIT | 3 | Hold | $12.00 | +65.52% | Downgrades | 4 months ago |
Jasper Therapeutics IncJSPR | 2 | Buy | $8.00 | +341.99% | Maintains | 5 months ago |
Ayala Pharmaceuticals IncAYLA | 4 | Hold | N/A | N/A | Downgrades | 5 months ago |
Relmada Therapeutics IncRLMD | 2 | Hold | N/A | N/A | Downgrades | 6 months ago |
Prothena Corp Public Ltd CoPRTA | 7 | Buy | $110.00 | +126.94% | Maintains | 6 months ago |
Enanta Pharmaceuticals IncENTA | 4 | Hold | $59.00 | +45.90% | Maintains | 8 months ago |
Sierra Oncology IncSRRA | 2 | Hold | $55.00 | +0.02% | Downgrades | a year ago |
Neurocrine Biosciences IncNBIX | 4 | Buy | $154.00 | N/A | Maintains | a year ago |
Sage Therapeutics IncSAGE | 4 | Buy | $80.00 | N/A | Maintains | a year ago |
Incyte CorpINCY | 6 | Buy | $109.00 | N/A | Maintains | a year ago |
Exelixis IncEXEL | 1 | Buy | $29.00 | N/A | Maintains | a year ago |
Focus Financial Partners IncFOCS | 1 | Buy | $71.00 | N/A | Maintains | a year ago |
Frequency Therapeutics IncFREQ | 2 | Buy | $20.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 3 | Buy | $148.00 | N/A | Maintains | 2 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | $46.00 | N/A | Downgrades | 3 years ago |
Bicycle Therapeutics PLCBCYC | 1 | Buy | $27.00 | N/A | Initiates Coverage On | 3 years ago |
Tempest Therapeutics IncTPST | 1 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Marinus Pharmaceuticals IncMRNS | 2 | Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Mediwound LtdMDWD | 1 | Buy | $84.00 | N/A | Maintains | 5 years ago |
Acorda Therapeutics IncACOR | 2 | Hold | $126.00 | N/A | Maintains | 5 years ago |
Medicines CoMDCO | 2 | Buy | N/A | N/A | Upgrades | 5 years ago |
Neuroderm LtdNDRM | 2 | Buy | $42.00 | N/A | Upgrades | 6 years ago |
Therapeuticsmd IncTXMD | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | N/A | N/A | Upgrades | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.